We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aggressive 'Culture of Approval' Harms FDA Drug Review Process, Witnesses Say
The item has been added to your shopping cart.
Aggressive 'Culture of Approval' Harms FDA Drug Review Process, Witnesses Say
February 16, 2007
A forceful “culture of approval” and attempts to muffle scientific dissent among agency reviewers have created significant problems in the FDA’s drug review process, witnesses at a House subcommittee hearing testified.